ArticleWorld journal of surgical oncology2026

Melittin enhances PD-L1 blockade in prostate cancer by inhibiting M2 macrophage polarization and recruitment.

Rucheng Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.